The role of integrative oncology in a tertiary prevention survivorship program

Preventive Medicine

Volumn 49, Issue 2-3, 2009, Pages 93-98

  Sagar, Stephen M ^a,b   Lawenda, Brian D ^c,d  

^a JURAVINSKI CANCER CENTRE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Complementary; Comprehensive; Integrative; Oncology; Prevention; Rehabilitation; Survivorship; Whole systems

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; BETA CAROTENE; CATECHIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; FOLIC ACID; GINSENG EXTRACT; HERBACEOUS AGENT; NATURAL PRODUCT; PLANT GLYCOSIDE; POLYSACCHARIDE; RESVERATROL;

ADJUVANT THERAPY; ALTERNATIVE MEDICINE; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BREAST CANCER; CANCER MORTALITY; CANCER PREVENTION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLON POLYP; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MEGADOSE; EARLY INTERVENTION; EMPOWERMENT; EVIDENCE BASED MEDICINE; EXERCISE; FOOD COMPOSITION; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; LIFESTYLE MODIFICATION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUTRITIONAL REQUIREMENT; ONCOLOGY; PHYSIOTHERAPY; PRECANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENCE RISK; REHABILITATION CARE; REVIEW; RISK REDUCTION; SELF CARE; SURVIVAL RATE; SURVIVAL TIME; SYMPTOM; TEA;

COMPLEMENTARY THERAPIES; DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; LIFE STYLE; MEDICAL ONCOLOGY; NEOPLASMS; SURVIVAL RATE;

EID: 70349289111     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2009.05.013     Document Type: Review

References (89)

1. Abrams D., and Weil A. Integrative Oncology (2009), Oxford University Press, New York, New York
2. Ader R. Conditioned immunomodulation: research needs and directions. Brain Behav. Immun. 17 1, Suppl.1 (2003) S51-S57
3. Ader R., and Cohen N. Behaviorally conditioned immunosuppression. Psychosom. Med. 37 4 (1975) 333-340
4. Ahuja R., Weibel S.B., and Leone F.T. Lung cancer: the oncologist's role in smoking cessation. Semin. Oncol. 30 1 (2003) 94-103
5. Alberts D.S., Martinez M.E., Roe D.J., et al. Lack of effect of a high-fi{ligature}ber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N. Engl. J. Med. 342 16 (2000) 1156-1162
6. Alpha-Tocopherol, Beta-Carotene Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330 15 (1994) 1029-1035
7. American Cancer Society. Cancer Facts and Figures (2007), American Cancer Society, Atlanta, GA
8. Anand P., Kunnumakkara A.B., Newman R.A., et al. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 6 (2007) 807-818
9. Andersen B.L., Farrar W.B., Golden-Kreutz D.M., et al. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J. Clin. Oncol. 22 17 (2004) 3570-3580
10. Andersen B.L., Yang H.C., Farrar W.B., Golden-Kreutz D.M., Emery C.F., Thornton L.M., et al. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer 113 12 (2008) 3450-3458
11. Bairati I., Meyer F., Gélinas M., et al. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J. Clin. Oncol. 23 24 (2005) 5805-5813
12. Bjelakovic G., Nikolova D., Gluud L.L., et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 29 (2007) 842-857
13. Bonithon-Kopp C., Kronborg O., Giacosa A., et al. Calcium and fi{ligature}bre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 356 9238 (2000) 1300-1306
14. Boon H., Verhoef M., O Hara D., et al. Integrative healthcare: arriving at a working definition. Altern. Ther. Health Med. 10 5 (2004) 48-56
15. Bovbjerg D.H. Conditioning, cancer, and immune regulation. Brain Behav. Immun. 17 1, Suppl.1 (2003) S58-S61
16. Cerhan J.R., Potter J.D., Gilmore J.M.E., et al. Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa Women's Health Study Cohort. Cancer Epidemiol. Biomark. Prev. 13 (2004) 1114-1120
17. Chang R. Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants. J. Altern. Complement. Med. 8 5 (2002) 559-565
18. Chlebowski R.T., Blackburn G.L., Thomson C.A., et al. Dietary fat reduction and breast cancer outcome: interim effi{ligature}cacy results from the Women's Intervention Nutrition Study. J. Natl. Cancer Inst. 98 24 (2006) 1767-1776
19. Cole B.F., Baron J.A., Sandler R.S., et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297 (2007) 2351-2359
20. Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. Dis. Colon Rectum 35 2 (1992) 123-130
21. Courneya K. Exercise in cancer survivors: an overview of research. Med. Sci. Sports Exerc. 35 11 (2003) 1846-1852
22. Del Giudice M.E., Fantus I.G., Ezzat S., et al. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res. Treat. 47 2 (1998) 111-120
23. Demark-Wahnefried W., Peterson B., McBride C., et al. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer 88 3 (2000) 674-684
24. Demark-Wahnefried W., Clipp E.C., Lipkus I.M., et al. Main outcomes of the FRESH START trial: a sequentially tailored, diet and exercise mailed print intervention among breast and prostate cancer survivors. J. Clin. Oncol. 25 19 (2007) 2709-2718
25. Dhillon N., Aggarwal B.B., Newman R.A., et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 14 (2008) 4491-4499
26. Emmons K., Li F.P., Whitton J., et al. Predictors of smoking initiation and cessation among childhood cancer survivors: s report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 20 6 (2002) 1608-1616
27. Gansler T., Kaw C., Crammer C., et al. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's Studies of Cancer Survivors. Cancer 113 5 (2008) 1048-1057
28. Goel A., Jhurani S., and Aggarwal B.B. Multi-targeted therapy by curcumin: how spicy is it?. Mol. Nutr. Food Res. 52 9 (2008) 1010-1030
29. Goodwin P.J. Weight gain in early breast cancer. Where do we go from here. J. Clin. Oncol. 19 9 (2001) 2367-2369
30. Goodwin P.J., Ennis M., Pritchard K.I., et al. Fasting insulin and outcome in early stage breast cancer: results of a prospective cohort study. J. Clin. Oncol. 20 1 (2002) 42-51
31. Gritz E.R., Fingeret M.C., Vidrine D.J., et al. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer 106 1 (2006) 17-27
32. Harikumar K.B., and Aggarwal B.B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7 8 (2008) 1020-1035
33. Hawkley L.C., and Cacioppo J.T. Loneliness and pathways to disease. Brain Behav. Immun. 17 1, Suppl.1 (2003) S98-S105
34. Hennekens C.H., Buring J.E., Manson J.E., et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334 18 (1996) 1145-1149
35. Hewitt M., Greenfield S., and Stovall E.L. Institute of Medicine and National Research Council: From Cancer Patient to Cancer Survivors: Lost in Transition (2005), National Academies Press, Washington, DC
36. Howard R.A., Freedman M., Park Y., et al. Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study. Cancer Cause Control 19 9 (2008) 939-953
37. Jones L.W., Courneya K.S., Fairey A.S., et al. Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial. Ann. Behav. Med. 28 2 (2004) 105-113
38. Jung W., and Irwin M. Reduction of natural killer cytotoxic activity in major depression: interaction between depression and cigarette smoking. Psychosom. Med. 61 (1999) 263-270
39. Larsson S.C., Mantzoros C.S., and Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int. J. Cancer 121 4 (2007) 856-862
40. Lawenda B.D., Kelly K.M., Ladas E.J., et al. Should supplemental dietary antioxidant administration be avoided during chemotherapy and radiation therapy?. J. Natl. Cancer Inst. 100 11 (2008) 773-783
41. Lee I.M., Cook N.R., Manson J.E., et al. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J. Natl. Cancer Inst. 91 24 (1999) 2102-2106
42. Ligibel J.A., Campbell N., Partridge A., et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J. Clin. Oncol. 26 6 (2008) 907-912
43. Lippman S.M., Levin B., Brenner D.E., et al. Cancer prevention and the American Society of Clinical Oncology. J. Clin. Oncol. 22 19 (2004) 3848-3851
44. Liu J., Xing J., and Fei Y. Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies. Chinese Med. 3 12 (2008)
45. Lutgendorf S.K., Lamkin D.M., DeGeest K., et al. Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients. Brain Behav. Immun. 22 6 (2008) 890-900
46. Mandelblatt J., and Kanetsky P.A. Effectiveness of interventions to enhance physician screening for breast cancer. J. Fam. Pract. 40 2 (1995) 162-171
47. Maunsell E., Drolet M., Brisson J., et al. Dietary change after breast cancer: extent, predictors, and relation with psychological distress. J. Clin. Oncol. 20 4 (2002) 1017-1025
48. Madden S.K. Catecholamines, sympathetic innervation, and immunity. Brain Behav. Immun. 17 1, Suppl1. (2003) S5-S10
49. Messina M.J., and Loprinzi C.L. Soy for breast cancer survivors: a critical review of the literature. J. Nutr. 131 (2001) 3095S-3108S
50. Meyer F., Bairati I., Fortin A., et al. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int. J. Cancer 122 7 (2008) 1679-1683
51. Meyerhardt J., Giovannucci E., Holmes M., et al. Physical activity and survival after colorectal cancer diagnosis. J. Clin. Oncol. 24 22 (2006) 3527-3534
52. Meyerhardt J., Heseltine D., Niedzwiecki D., et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J. Clin. Oncol. 24 22 (2006) 3535-3541
53. Michael Y.L., Berkman L.F., Colditz G.A., et al. Social networks and health-related quality of life in breast cancer survivors: a prospective study. J. Psychosom. Res. 52 5 (2002) 285-293
54. Michels K.B. The role of nutrition in cancer development and prevention. Int. J. Cancer 114 2 (2005) 163-165
55. Michels K.B., Giovannucci E., Joshipura K.J., et al. A prospective study of fruit and vegetable consumption and colorectal cancer incidence. J. Natl. Cancer Inst. 92 21 (2000) 1740-17452
56. Michels K.B., Fuchs C.S., Giovannucci E., et al. Fiber intake and incidence of colorectal cancer among 76,947 women and 47,279 men. Cancer Epidemiol. Biomark. Prev. 14 (2005) 842-849
57. Miller A.H., Ancoli-Israel S., Bower J.E., et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J. Clin. Oncol. 26 6 (2008) 971-982
58. Omenn G.S., Goodman G.E., Thornquist M.D., et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334 18 (1996) 1150-1155
59. Ornish D., Weidner G., Fair W.R., et al. Intensive lifestyle changes may affect the progression of prostate cancer. J. Urol. 174 3 (2005) 1065-1069
60. Ornish D., Lin J., Daubenmier J., et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 9 11 (2008) 1048-1057
61. Park Y., Hunter D.J., Spiegelman D., et al. Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 294 (2005) 2849-2857
62. Pasanisi P., Berrino F., De Petris M., et al. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int. J. Cancer 119 1 (2006) 236-238
63. Patel A.V., Feigelson H.P., Talbot J.T., et al. The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women. Int. J. Cancer 123 8 (2008) 1877-1882
64. Peto R., Doll R., Buckley J.D., et al. Can dietary beta-carotene materially reduce human cancer rates?. Nature 290 (1981) 201-208
65. Physical Activity Guidelines for Americans 2008. www.health.gov/paguidelines, accessed December 30, 2008.
66. Pierce J.P., Natarajan L., Caan B.J., et al. Infl{ligature}uence of a diet very high in vegetables, fruit, and fi{ligature}ber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 298 (2007) 289-298
67. Pierce J., Stefanick M., Flatt W., et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J. Clin. Oncol. 25 17 (2007) 2345-2351
68. Price M.A., Tennant C.C., Butow P.N., et al. The role of psychosocial factors in the development of breast carcinoma: part II. Cancer 91 4 (2001) 686-697
69. Rimer B.K. Improving the use of cancer screening for older women. Cancer 72 Suppl. 3 (1993) 1084-1087
70. Ritenbaugh C., Verhoef M., Fleishman S., et al. Whole systems research: a discipline for studying complementary and alternative medicine. Altern. Ther. Health Med. 9 4 (2003) 32-36
71. Sagar S. Integrative oncology in North America. J. Soc. Integr. Oncol. 4 1 (2006) 27-39
72. Sagar S.M., and Wong R.K. Chinese medicine and biomodulation in cancer patients-part two. Curr. Oncol. 15 2 (2008) 78
73. Sagar S.M., and Leis S.M. Integrative oncology: a Canadian and international perspective. Curr. Oncol. 15 (2008) S71-S73
74. Saxe G.A., Major J.M., Westerberg L., et al. Biological mediators of effect of diet and stress reduction on prostate cancer. Integr. Cancer Ther. 7 3 (2008) 130-138
75. Shankar S., Singh G., and Srivastava R.K. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front. Biosci. 12 (2007) 4839-4854
76. Schatzkin A., Lanza E., Corle D., et al. Lack of effect of a low-fat, high-fi{ligature}ber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N. Engl. J. Med. 342 16 (2000) 1149-1155
77. Schmitz K.H., Holtzman J., Courneya K.S., et al. Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol. Biomark. Prev. 14 (2005) 1588-1595
78. Sood A.K., Bhatty R., Kamat A.A., et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin. Cancer Res. 12 (2006) 369-375
79. Su F., Ouyang N., Zhu P., et al. Psychological stress induces chemoresistance in breast cancer by upregulating mdr1. Biochem. Biophys. Res. Commun. 329 3 (2005) 888-897
80. US Department of Health and Human Services. Physical activity and health: a report of the surgeon general. National Center for Chronic Disease Prevention and Health Promotion (1996) Washington DC
81. Virtamo J., Pietinen P., Huttunen J.K., et al. ATBC Study Group. ATBC Study Group. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a post-intervention follow-up. JAMA 290 4 (2003) 476-485
82. Warri A., Saarinen N.M., Makela S., et al. The role of early life genistein exposures in modifying breast cancer risk. Br. J. Cancer 98 9 (2008) 1485-1493
83. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective (2007), AICR, Washington DC
84. Yance D.R., and Sagar S.M. Targeting angiogenesis with integrative cancer therapies. Integr. Cancer Ther. 5 1 (2006) 9-29
85. Yang E.V., and Glaser R. Stress-induced immunomodulation: implications for tumorigenesis. Brain Behav. Immun. 17 1, suppl.1 (2003) S37-S40
86. Yang E.V., Sood A.K., Chen M., et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res. 66 (2006) 10357-10364
87. Yang E., Donovan E.L., Benson D.M., et al. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav. Immun. 22 3 (2008) 318-323
88. Yang E.V., Kim S.-J., Donovan E.L., et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav. Immun. (2008) 10.1016/j.bbi.2008.10.005 Electronic publication ahead of print, Oct 21
89. Yarnall K.S., Pollak K.I., Ostbye T., et al. Primary care: is there enough time for prevention?. Am. J. Public Health 93 4 (2003) 635-641